• 1. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 4. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

• Material Chemicals Electrical Materials Nanoelectronic Materials
• Catalysts and Inorganic Chemicals Inorganic Compounds Oxides
• Catalysts and Inorganic Chemicals Inorganic Compounds Salt
• Material Chemicals High Polymer Materials
• Catalysts and Inorganic Chemicals Inorganic Compounds

Titanium Dioxide (13463-67-7) in Pharmaceutical Applications: A Comprehensive Review

Titanium dioxide (TiO₂, CAS 13463-67-7) is a versatile inorganic compound widely used in the pharmaceutical and biomedical industries due to its unique physicochemical properties. As a UV-filtering agent, it plays a critical role in sunscreen formulations, protecting skin from harmful radiation while minimizing oxidative stress. Recent studies highlight its potential in drug delivery systems, where its high surface area and biocompatibility enable controlled release of therapeutics. Researchers are particularly interested in its nano-formulations (TiO₂ NPs), which enhance bioavailability for poorly soluble drugs like anticancer agents. However, regulatory agencies emphasize rigorous toxicity assessments, especially for inhalable forms, to address long-term biosafety concerns—a topic dominating 2023’s pharmaceutical discourse.

How Titanium Dioxide (13463-67-7) Enhances Drug Delivery Systems

The application of titanium dioxide (13463-67-7) in nanoparticle-based drug carriers has revolutionized targeted therapy. Its photocatalytic properties allow light-triggered drug release, a breakthrough for precision medicine in oncology. For instance, TiO₂-coated liposomes demonstrate improved stability and tumor-specific accumulation in preclinical trials. Additionally, its antibacterial properties are leveraged in wound dressings and implant coatings to prevent infections—a key focus for biomedical startups. Despite these advances, challenges like particle aggregation and inflammatory responses require further optimization, as noted in recent Journal of Controlled Release publications.

Safety and Regulatory Status of Titanium Dioxide (13463-67-7) in Medicine

Debates surrounding the safety profile of titanium dioxide (13463-67-7) intensified after the European Food Safety Authority’s 2021 classification as a potential carcinogen (Category 2). In pharmaceuticals, however, its use remains approved in topical and oral formulations (e.g., tablet coatings) under strict particle size regulations. The FDA’s 2023 draft guidance mandates in-vitro genotoxicity testing for nano-TiO₂ in inhalable drugs, reflecting growing scrutiny. Patients and manufacturers alike seek clarity on alternatives like zinc oxide, though TiO₂’s superior refractive index maintains its dominance in UV-protective therapies.

Future Trends: Titanium Dioxide (13463-67-7) in Biomedical Innovation

Emerging research explores titanium dioxide (13463-67-7) in photodynamic therapy (PDT) for resistant infections and cancer. A 2023 Nature Materials study revealed TiO₂-based composites that generate reactive oxygen species (ROS) under low-energy light, minimizing tissue damage. Another frontier is bioimaging, where TiO₂ quantum dots serve as contrast agents with negligible cytotoxicity. With the global nanomedicine market projected to exceed $350 billion by 2030, investments in TiO₂ functionalization technologies—such as PEGylation for stealth effects—are surging, aligning with demand for personalized therapeutics.

Titanium Dioxide (13463-67-7) vs. Other Excipients: Performance and Cost Analysis

Pharmaceutical formulators often compare titanium dioxide (13463-67-7) with alternatives like silica or calcium carbonate for opacity and flow enhancement. While TiO₂ offers superior whiteness (98% reflectance) and FDA compliance for oral solids, its higher cost (≈$15/kg) drives research into hybrid coatings. A 2022 International Journal of Pharmaceutics analysis showed that TiO₂-magnesium stearate blends reduce tablet sticking by 40% without compromising dissolution—a critical factor for generic drug manufacturers. Sustainability concerns also prompt innovations in recycled TiO₂ from industrial byproducts, appealing to eco-conscious brands.

• 200138-22-3(Titanate (Ti3O61-))
• 200138-23-4(Titanate (Ti4O81-))
• 98084-96-9(dioxotitanium)
• 12188-41-9(Titanium(IV) oxide, brookite)
• 1317-80-2(Titanium Dioxide)
• 112153-70-5(Aerosil R 805)
• 129316-41-2(Titanium(1+), dioxo- (9CI))
• 1317-70-0(Titanium dioxide)
• 12259-65-3(Titanate (TiO32-)(8CI,9CI))
• 12214-43-6(Titanium oxide (TiO2), hydrate (8CI,9CI))